ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


Von Hippel-Lindau Disease: An Overview
 (Vol 34/No. 4. On-line test expires: 08/20/2009)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Michele Inglese, MSN, RN, CNN
 Michele Inglese, MSN, RN, CNN, is Clinical Instructor, UMDNJ School of Nursing, Newark NJ and Staff Nurse, Hackensack University Medical Center, Rutherford, NJ. She is a member of ANNA’s Jersey North Chapter. For more information on this article, contact the author at j-minglese@ mindspring.com.
  OUTLINE

Von Hippel-Lindau disease is a rare, familial disease consisting of multiple tumors, which can present in the eyes, brain, adrenal gland, pancreas, liver, spinal cord, kidneys, or other areas of the body. The renal tumors are primarily renal cell carcinoma. Renal involvement may be the primary manifestation, but most frequently it is a secondary manifestation. This article presents an overview of von Hippel-Lindau disease and the nursing care of the patient with renal involvement.
  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.0 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses’ Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910; and the Kansas State Board of Nursing, Provider No. LT0148-0738. This offering is accepted for RN and LPN relicensure in Kansas

  EDUCATIONAL OBJECTIVES

Goal:
To inform nephrology nurses about the manifestations and treatment for the renal involvement of Von Hippel-Lindau Disease

Objectives:
1. Describe the genetic basis for the tumor development in Von Hippel-Lindau Disease.
2. Compare the treatments used for patients with renal carcinomas caused by Von Hippel-Lindau Disease.
3. Develop an education plan for patients with a family history of Von Hippel-Lindau Disease.

AUTHOR DISCLOSURE STATEMENT
Michele Inglese has no conflicts of interest to disclose.

 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.